Clinical Trial Update: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of Relugolix for heavy menstrual bleeding associated with uterine fibroids; study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding
• Uterine Fibroids

Drugs mentioned

• Relugolix (Relugolix)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Heavy Menstrual Bleeding, Uterine Fibroids | Phase 3 | Status: RECRUITING